Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer
Completed · Phase 2
Conditions studied: Kidney Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Prednisone may help to relieve symptoms in patients with recurrent and/or metastatic kidney cancer. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy consisting of vinorelbine and estramustine with or without prednisone in treating patients who have recurrent and/or metastatic kidney cancer.
Key facts
- Study ID
- NCT00003584
- Run by
- University of New Mexico
- People needed
- 35
- Starts
- 1998-07-01
- Expected to finish
- 2000-12-01
- Last updated by the study team
- 2016-05-12
Who can join
Age: any, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of New Mexico Cancer Research & Treatment Center — Albuquerque, New Mexico, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.